Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue 1
Submit an article Journal homepage
129
Views
3
CrossRef citations to date
0
Altmetric
Other Disease

A low initial botulinum toxin A treatment response does not predict poor long-term outcomes in patients with axillary bromhidrosis

Jinguang HeDepartment of Plastic and Reconstructive Surgery, Shanghai 9th People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China
,
Tao WangDepartment of Plastic and Reconstructive Surgery, Shanghai 9th People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. ChinaCorrespondence[email protected]
&
Jiasheng DongDepartment of Plastic and Reconstructive Surgery, Shanghai 9th People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China
Pages 102-104 | Received 22 Mar 2017, Accepted 04 May 2017, Published online: 31 May 2017

References

  • He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with botulinum toxin A. J Dermatolog Treat. 2012;23:461–4.
  • He J, Wang T, Dong J. Excision of apocrine glands and axillary superficial fascia as a single entity for the treatment of axillary bromhidrosis. J Eur Acad Dermatol Venereol. 2012;26:704–9.
  • Li ZR, Sun CW, Zhang JY, et al. Excision of apocrine glands with preservation of axillary superficial fascia for the treatment of axillary bromhidrosis. Dermatol Surg. 2015;41:640–4.
  • Heckmann M, Teichmann B, Pause BM, Plewig G. Amelioration of body odor after intracutaneous axillary injection of botulinum toxin A. Arch Dermatol. 2003;139:57–9.
  • Del Boz J, Padilla-Espana L, Segura-Palacios JM. Botulinum toxin injection technique for axillary hyperhidrosis. Actas Dermosifiliogr. 2014;105:517–18.
  • De Almeida AR, Montagner S. Botulinum toxin for axillary hyperhidrosis. Dermatol Clin. 2014;32:495–504.
  • Rompel R, Scholz S. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2001;15:207–11.
  • Brehmer F, Lockmann A, Gronemeyer LL, et al. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients. J Dtsch Dermatol Ges. 2015;13:799–805.
  • Lecouflet M, Leux C, Fenot M, et al. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients. J Am Acad Dermatol. 2013;69:960–4.
  • Lecouflet M, Leux C, Fenot M, et al. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis: a study of 28 patients. J Am Acad Dermatol. 2014; 70:1083–7.
  • Dressler D, Saberi FA. Safety of botulinum toxin short interval therapy using incobotulinumtoxin A. J Neural Transm (Vienna). 2017;124:437–40.
  • Lowe PL, Cerdan-Sanz S, Lowe NJ. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments. Dermatol Surg. 2003;29:545–8.
  • Bechara FG, Sand M, Hoffmann K, et al. Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis. Dermatol Surg. 2008;34:1001–9.
  • Denys P, Dmochowski R, Aliotta P, et al. Positive outcomes with first onabotulinumtoxin A treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivity. BJU Int. 2017. doi: 10.1111/bju.13795.
  • Dressler D, Saberi FA. Towards a dose optimisation of botulinum toxin therapy for axillary hyperhidrosis: comparison of different Botox(®) doses. J Neural Transm (Vienna). 2013;120:1565–7.
  • Wollina U, Karamfilov T. Botulinum toxin A for palmar hyperhidrosis. J Eur Acad Dermatol Venereol. 2001;15:555–8.
  • Dressler D, Münchau A, Bhatia KP, et al. Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses? Eur Neurol. 2002;47:118–21.
  • Dressler D, Wohlfahrt K, Meyer-Rogge E. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dermatol Surg. 2010;36:2182–7.
  • Molenaers G, Van Campenhout A, Fagard K, et al. The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. J Child Orthop. 2010;4:183–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.